169 related articles for article (PubMed ID: 23865107)
21. Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics.
Tan H; Zhang H; Yang W; Fu Y; Gu Y; Du M; Cheng D; Shi H
Nucl Med Commun; 2016 Aug; 37(8):792-9. PubMed ID: 27058361
[TBL] [Abstract][Full Text] [Related]
22. MRI versus breast-specific gamma imaging (BSGI) in newly diagnosed ductal cell carcinoma-in-situ: a prospective head-to-head trial.
Keto JL; Kirstein L; Sanchez DP; Fulop T; McPartland L; Cohen I; Boolbol SK
Ann Surg Oncol; 2012 Jan; 19(1):249-52. PubMed ID: 21739318
[TBL] [Abstract][Full Text] [Related]
23. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
[TBL] [Abstract][Full Text] [Related]
24. Breast-specific gamma imaging for the detection of breast cancer in dense versus nondense breasts.
Rechtman LR; Lenihan MJ; Lieberman JH; Teal CB; Torrente J; Rapelyea JA; Brem RF
AJR Am J Roentgenol; 2014 Feb; 202(2):293-8. PubMed ID: 24450668
[TBL] [Abstract][Full Text] [Related]
25. Computer-aided detection (CAD) in mammography.
TEC Bull (Online); 2002 Nov; 19(3):18-27. PubMed ID: 12839023
[No Abstract] [Full Text] [Related]
26. Magnetic resonance imaging of the breast in screening women considered to be at high genetic risk of breast cancer.
TEC Bull (Online); 2003 Nov; 20(3):12-4. PubMed ID: 15043078
[No Abstract] [Full Text] [Related]
27. Results of a multicenter patient registry to determine the clinical impact of breast-specific gamma imaging, a molecular breast imaging technique.
Weigert JM; Bertrand ML; Lanzkowsky L; Stern LH; Kieper DA
AJR Am J Roentgenol; 2012 Jan; 198(1):W69-75. PubMed ID: 22194518
[TBL] [Abstract][Full Text] [Related]
28. Tc-99m sestamibi scintimammography: where is it now?
Schillaci O; Scopinaro F
Cancer Biother Radiopharm; 1999 Dec; 14(6):417-22. PubMed ID: 10850328
[No Abstract] [Full Text] [Related]
29. FDG PET for evaluating breast cancer.
Tecnologica MAP Suppl; 2001 Apr; ():7-13. PubMed ID: 11718146
[No Abstract] [Full Text] [Related]
30. Breast MRI for detection or diagnosis of primary or recurrent breast cancer.
Technol Eval Cent Assess Program Exec Summ; 2004 Apr; 19(1):1-9. PubMed ID: 15314823
[No Abstract] [Full Text] [Related]
31. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
Kim JS; Lee SM; Cha ES
Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
[TBL] [Abstract][Full Text] [Related]
32. Scientific Impact Recognition Award: Molecular breast imaging: a review of the Mayo Clinic experience.
Hruska CB; Boughey JC; Phillips SW; Rhodes DJ; Wahner-Roedler DL; Whaley DH; Degnim AC; O'Connor MK
Am J Surg; 2008 Oct; 196(4):470-6. PubMed ID: 18723155
[TBL] [Abstract][Full Text] [Related]
33. Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts.
Rhodes DJ; Hruska CB; Phillips SW; Whaley DH; O'Connor MK
Radiology; 2011 Jan; 258(1):106-18. PubMed ID: 21045179
[TBL] [Abstract][Full Text] [Related]
34. The role of nuclear medicine in breast cancer detection: a focus on Technetium-99 Sestamibi scintimammography.
Romero L; Khalkhali I; Vargas HI
Curr Oncol Rep; 2003 Jan; 5(1):58-62. PubMed ID: 12493151
[TBL] [Abstract][Full Text] [Related]
35. The role of planar scintimammography with high-resolution dedicated breast camera in the diagnosis of primary breast cancer.
Spanu A; Chessa F; Meloni GB; Sanna D; Cottu P; Manca A; Nuvoli S; Madeddu G
Clin Nucl Med; 2008 Nov; 33(11):739-42. PubMed ID: 18936602
[TBL] [Abstract][Full Text] [Related]
36. Molecular breast imaging with gamma emitters.
Schillaci O; Spanu A; Danieli R; Madeddu G
Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):340-51. PubMed ID: 24322791
[TBL] [Abstract][Full Text] [Related]
37. Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging.
Brem RF; Ioffe M; Rapelyea JA; Yost KG; Weigert JM; Bertrand ML; Stern LH
AJR Am J Roentgenol; 2009 Feb; 192(2):379-83. PubMed ID: 19155397
[TBL] [Abstract][Full Text] [Related]
38. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
39. Real-world application of breast-specific gamma imaging, initial experience at a community breast center and its potential impact on clinical care.
Zhou M; Johnson N; Blanchard D; Bryn S; Nelson J
Am J Surg; 2008 May; 195(5):631-5; discussion 635. PubMed ID: 18374889
[TBL] [Abstract][Full Text] [Related]
40. Tc-99m-methoxy isobutyl isonitrile scintimammography: imaging postexcision biopsy for residual and multifocal breast tumor.
Usmani S; Khan HA; Niaz K; Uz-Zaman M; Niyaz K; Javed A; al Mohannadi S; Abu al Huda F; Kamal S
Nucl Med Commun; 2008 Sep; 29(9):826-9. PubMed ID: 18677211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
